Tiago Fauth Analyst Performance

Director - Equity Research Small/Mid Cap Biotechnology at Wells Fargo & Company

Tiago Fauth is a stock analyst at Wells Fargo & Company in the medical sector, covering 18 publicly traded companies. Over the past year, Tiago Fauth has issued 30 stock ratings, including buy and hold recommendations. While full access to Tiago Fauth's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Tiago Fauth's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 35 Last 5 Years
Buy Recommendations: 62.86% 22 Buy Ratings
Companies Covered: 18 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	62.9%	22 ratings
Hold	37.1%	13 ratings
Sell	0.0%	0 ratings

Out of 35 total stock ratings issued by Tiago Fauth at Wells Fargo & Company, the majority (62.9%) have been Buy recommendations, followed by 37.1% Hold.

Best & Worst Calls

Best Call
000.0%
FMTX
Dec 2020
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	100.0% of companies on NASDAQ	18 companies

Tiago Fauth, an analyst at Wells Fargo & Company, currently covers 18 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 18 companies	100.0%

Tiago Fauth of Wells Fargo & Company specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 14 companies	77.8%
MED - DRUGS 1 company	5.6%
MED - GENERIC DRG 1 company	5.6%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC 1 company	5.6%
BIOTECHNOLOGY 1 company	5.6%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
WVE WAVE Life Sciences	9/4/2025	Lower Price Target	$8.00	$18.00	Overweight
INSM Insmed	9/3/2025	Boost Price Target	$145.30	$171.00	Overweight
UTHR United Therapeutics	9/3/2025	Boost Price Target	$404.27	$414.00	Equal Weight
MNKD MannKind	9/3/2025	Boost Price Target	$5.63	$10.00	Overweight
PTCT PTC Therapeutics	8/20/2025	Lower Price Target	$48.30	$73.00	Overweight
LQDA Liquidia Technologies	8/13/2025	Boost Price Target	$24.10	$31.00	Overweight
INSM Insmed	8/12/2025	Boost Price Target	$122.00	$140.00	Overweight
PTCT PTC Therapeutics	8/8/2025	Boost Price Target	$46.28	$79.00	Overweight
ALNY Alnylam Pharmaceuticals	8/1/2025	Boost Price Target	$395.93	$395.00	Equal Weight
WVE WAVE Life Sciences	7/31/2025	Lower Price Target	$8.32	$21.00	Overweight
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
UTHR United Therapeutics	7/31/2025	Lower Price Target	$278.91	$295.00	Equal Weight
PTCT PTC Therapeutics	7/29/2025	Boost Price Target	$48.86	$78.00	Overweight
INSM Insmed	7/22/2025	Boost Price Target	$103.27	$130.00	Overweight
VRNA Verona Pharma PLC American Depositary Share	7/10/2025	Downgrade	$104.77	$107.00	Hold
RARE Ultragenyx Pharmaceutical	7/10/2025	Lower Price Target	$30.25	$65.00	Overweight
BBIO BridgeBio Pharma	6/30/2025	Boost Price Target	$44.24	$76.00	Overweight
ALNY Alnylam Pharmaceuticals	6/30/2025	Boost Price Target	$324.99	$333.00	Equal Weight
VRNA Verona Pharma PLC American Depositary Share	6/20/2025	Boost Price Target	$90.92	$138.00	Overweight
INSM Insmed	6/11/2025	Boost Price Target	$90.93	$119.00	Overweight
PTCT PTC Therapeutics	5/27/2025	Boost Price Target	$45.93	$74.00	Overweight
INZY Inozyme Pharma	5/16/2025	Reiterated Rating	$3.95	$4.00	Equal Weight
VRNA Verona Pharma PLC American Depositary Share	4/30/2025	Boost Price Target	$72.46	$107.00	Overweight
UTHR United Therapeutics	4/25/2025	Reiterated Rating	$296.42	$314.00	Equal Weight
ALNY Alnylam Pharmaceuticals	3/21/2025	Boost Price Target	$253.60	$287.00	Equal Weight
TECX Tectonic Therapeutic	3/21/2025	Lower Price Target	$20.58	$101.00	Overweight
KROS Keros Therapeutics	2/27/2025	Lower Price Target	$11.35	$26.00	Overweight
FOLD Amicus Therapeutics	2/20/2025	Lower Price Target	$9.56	$17.00	Overweight
INSM Insmed	2/19/2025	Boost Price Target	$81.36	$107.00	Overweight
PLRX Pliant Therapeutics	2/10/2025	Downgrade	$7.79	$4.00	Equal Weight
INZY Inozyme Pharma	1/13/2025	Lower Price Target	$1.75	$11.00	Overweight

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.